“NON-INVASIVE MONITORING OF EGFR MUTATIONS IN NONSMALL CELL LUNG CANCER (NSCLC) DURING TARGETED THERAPY: STATE OF THE ART AND OUR EXPERIENCE”, Вопр. онкол., vol. 62, no. 4, pp. 513–518, Dec. 2016, doi: 10.37469/0507-3758-2016-62-4-513-518.